- PhD - Pathology and Microbiology with Cancer Research emphasis, University of Nebraska Medical Center
- BS - Biology, Minor Chemistry, Truman State University
- Pediatric and young adult cancers
- Prostate cancer
Danielle Daee, PhD, is a program director in the Genomic Epidemiology Branch (GEB) of the Epidemiology and Genomics Research Program (EGRP) in NCI's Division of Cancer Control and Population Sciences (DCCPS). She manages a portfolio of grants related to genetic factors modulating susceptibility to cancers, including prostate, pediatric and adolescent/young adult cancers. Notably, Dr. Daee represents DCCPS on the Gabriella Miller Kids First Pediatric Research Program leadership team. She also supports the assessment and evaluation of several ongoing EGRP initiatives and has interests in functional genomics. Recently, Dr. Daee led several research initiatives in support of the Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act including RFA-CA-19-033, RFA-CA-20-027, and RFA-CA-20-028.
Prior to joining EGRP, Dr. Daee was a health science analyst in NCI's Office of Science Planning and Assessment (OSPA), where she evaluated the impact of NCI’s research investments through program evaluations and portfolio analyses. Prior to joining NCI, Dr. Daee developed an expertise in DNA repair, DNA replication, and yeast genetics through a postdoctoral fellowship at the National Human Genome Research Institute (NHGRI).
See listing of articles authored by Dr. Daee in PubMed.